BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31183628)

  • 21. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
    Albillos A; Bañares R; González M; Catalina MV; Molinero LM
    J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS).
    Sturm L; Bettinger D; Giesler M; Boettler T; Schmidt A; Buettner N; Thimme R; Schultheiss M
    United European Gastroenterol J; 2018 Nov; 6(9):1380-1390. PubMed ID: 30386611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Hung TH; Lee HF; Tseng CW; Tsai CC; Tsai CC
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):353-359. PubMed ID: 29551615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
    Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
    World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
    Yoon JS; Hong JH; Park SY; Kim SU; Kim HY; Kim JY; Hur MH; Park MK; Lee YB; Lee HA; Kim GA; Sinn DH; Park SJ; Lee YJ; Kim YJ; Yoon JH; Lee JH
    Aliment Pharmacol Ther; 2024 Apr; 59(8):973-983. PubMed ID: 38389319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.
    Tergast TL; Wranke A; Laser H; Gerbel S; Manns MP; Cornberg M; Maasoumy B
    Liver Int; 2018 Sep; 38(9):1602-1613. PubMed ID: 29675988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis.
    Zhou GP; Jiang YZ; Sun LY; Zhu ZJ
    Eur Radiol; 2021 Jul; 31(7):5390-5399. PubMed ID: 33409783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan.
    Sakamaki A; Kamimura K; Yokoo T; Osaki A; Yoshikawa S; Arao Y; Setsu T; Kamimura H; Waguri N; Takeuchi M; Funakoshi K; Terai S
    Medicine (Baltimore); 2021 Aug; 100(32):e26902. PubMed ID: 34397919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.
    Cheungpasitporn W; Thongprayoon C; Kittanamongkolchai W; Srivali N; Edmonds PJ; Ungprasert P; O'Corragain OA; Korpaisarn S; Erickson SB
    Ren Fail; 2015 Aug; 37(7):1237-41. PubMed ID: 26108134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis.
    Trikudanathan G; Israel J; Cappa J; O'Sullivan DM
    Int J Clin Pract; 2011 Jun; 65(6):674-8. PubMed ID: 21564440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitors' use and risk of hip fracture: a systematic review and meta-analysis.
    Hussain S; Siddiqui AN; Habib A; Hussain MS; Najmi AK
    Rheumatol Int; 2018 Nov; 38(11):1999-2014. PubMed ID: 30159775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: A meta-analysis update.
    Zhang H; Zhang H; Li H; Zhang H; Zheng D; Sun CM; Wu J
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):475-485. PubMed ID: 28786052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients.
    Fasullo M; Rau P; Liu DQ; Holzwanger E; Mathew JP; Guilarte-Walker Y; Szabo G
    World J Hepatol; 2019 Jun; 11(6):522-530. PubMed ID: 31293720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding: A Meta-analysis.
    Qi X; Jia J; Bai M; Guo X; Su C; García-Pagán JC; Han G; Fan D
    J Clin Gastroenterol; 2015 Jul; 49(6):495-505. PubMed ID: 25127113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparision between portosystemic shunts and endoscopic therapy for prevention of variceal re-bleeding: a systematic review and meta-analysis.
    Zhou GP; Sun LY; Wei L; Qu W; Zeng ZG; Liu Y; Jiang YZ; Zhu ZJ
    Chin Med J (Engl); 2019 May; 132(9):1087-1099. PubMed ID: 30913064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis.
    Li M; Luo Z; Yu S; Tang Z
    Medicine (Baltimore); 2019 Feb; 98(7):e14422. PubMed ID: 30762748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.